These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2123506)

  • 1. [Hepatitis C virus infection in patients treated with hemodialysis].
    Teruel JL; Fernández Muñoz R; Gámez C; Marcén R; Celma ML; Liaño F; Ortuño J
    Med Clin (Barc); 1990 Jun; 95(3):81-3. PubMed ID: 2123506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of hepatitis C virus antibodies in a hemodialysis unit].
    Rodríguez MI; Estay R; Soto JR; Wolff C; Plubins L; Child R; Armas R
    Rev Med Chil; 1993 Feb; 121(2):152-5. PubMed ID: 7508140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prevalence of anti-hepatitis virus C antibodies in chronic hemodialysis patients].
    Camps DH; Azcona S; Bertola S; Kohn I; Noguera E; Garzón Maceda F; Bongiorno E; Massari P; De Arteaga J
    Medicina (B Aires); 1992; 52(6):511-5. PubMed ID: 1340899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
    González-Michaca L; Mercado A; Gamba G
    Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca].
    Boulaajaj K; Elomari Y; Elmaliki B; Madkouri B; Zaid D; Benchemsi N
    Nephrol Ther; 2005 Nov; 1(5):274-84. PubMed ID: 16895696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
    Resić H; Sahović V; Mesić E; Leto E
    Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
    Chan TM; Lok AS; Cheng IK; Chan RT
    Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
    Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
    Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to hepatitis C virus increases with time on hemodialysis.
    Hardy NM; Sandroni S; Danielson S; Wilson WJ
    Clin Nephrol; 1992 Jul; 38(1):44-8. PubMed ID: 1499168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for hepatitis C in hemodialysis and its impact on the waiting list for kidney transplantation].
    Méndez Chacón P; Vidalón A; Vildosola H
    Rev Gastroenterol Peru; 2005; 25(1):12-8. PubMed ID: 15818418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and epidemiology of hepatitis C infection in patients on peritoneal dialysis in France. French PD centers.
    Durand PY; Chanliau J; Gamberoni J; Hestin D; Kessler M
    Adv Perit Dial; 1996; 12():167-70. PubMed ID: 8865894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.